ADVENTRX Pharmaceuticals to Present at the BIOCOM Investor Conference on October 26
15 Oktober 2009 - 10:15PM
PR Newswire (US)
SAN DIEGO, Oct. 15 /PRNewswire-FirstCall/ -- ADVENTRX
Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the
Company's Principal Executive Officer, Brian M. Culley, will
present at the BIOCOM Investor Conference on Monday, October 26,
2009, at 10:00 a.m. Pacific time, at the Hyatt Regency in La Jolla,
California. Interested parties can access a live audio webcast and
slide presentation on the ADVENTRX Pharmaceuticals Web site at
http://www.adventrx.com/. An archived presentation will be
available on the Web site for 30 days. About ADVENTRX
Pharmaceuticals ADVENTRX Pharmaceuticals is a specialty
pharmaceutical company whose product candidates are designed to
improve the safety of existing cancer treatments. More information
can be found on the Company's web site at http://www.adventrx.com/.
DATASOURCE: ADVENTRX Pharmaceuticals, Inc. CONTACT: Brian Culley,
Principal Executive Officer of ADVENTRX Pharmaceuticals,
+1-858-552-0866; or Investors, Don Markley of Lippert/Heilshorn
& Associates, Inc., +1-310-691-7100, , for ADVENTRX
Pharmaceuticals Web Site: http://www.adventrx.com/
Copyright